🎧 ▶️ Press play below to listen.
Introduction
Lithium is best known as one of the oldest and most effective medicines for bipolar disorder. But beyond its reputation in psychiatry, lithium is also a naturally occurring mineral with fascinating effects on the human brain.
Over the past few decades, research has uncovered that lithium doesn’t just stabilize mood—it can physically reshape the brain, protect nerve cells from damage, and even lower the risk of suicide. These findings make lithium one of the most unique substances in medicine: it not only treats symptoms, but it may actually change the course of mental health and brain aging.
In this article, we’ll explore lithium’s effects on brain structure and function, how it reduces suicide risk, what the evidence says about microdoses of lithium, and why this mineral continues to attract global scientific attention.
Lithium’s Effects on the Brain
1. Increasing Brain Volume
MRI studies have consistently shown that people taking lithium for bipolar disorder often have larger hippocampus and amygdala volumes compared to those not taking the drug.
- The hippocampus plays a crucial role in memory and learning.
- The amygdala helps regulate fear, anxiety, and emotional reactivity.
In bipolar disorder and depression, these regions often shrink over time. Lithium appears to reverse or prevent this shrinkage.
A meta-analysis from Bipolar Disorders (Hallahan et al., 2011) demonstrated that lithium users had increased gray matter volume in these emotion-regulating structures compared to non-users.
This suggests lithium isn’t just masking symptoms—it’s physically protecting and reshaping the brain.
2. Stimulating Neurogenesis and Synaptic Plasticity
Lithium has been shown to:
- Boost BDNF (Brain-Derived Neurotrophic Factor), a protein that encourages new neuron growth.
- Stimulate neurogenesis (the birth of new neurons), especially in the hippocampus.
- Improve synaptic plasticity, making brain cells more adaptable and better at forming new connections.
These changes may explain why lithium improves both mood stability and cognitive performance in patients who respond well to it.
3. Inhibiting Cell Death Pathways
On a molecular level, lithium blocks an enzyme called GSK-3β (glycogen synthase kinase-3 beta). This enzyme regulates many brain pathways, including those that can trigger cell death (apoptosis) and the abnormal buildup of tau protein seen in Alzheimer’s disease.
The discovery that lithium directly inhibits GSK-3β was first reported by Klein and Melton (1996), demonstrating that lithium competes with magnesium at the enzyme’s active site and alters key signaling pathways [Klein & Melton 1996].
Later studies confirmed that lithium inhibits GSK-3β in two ways: directly, and indirectly by promoting its phosphorylation, which turns the enzyme “off” [Jope 2003]. More recent reviews emphasize that this inhibition leads to broad neuroprotective and anti-inflammatory effects, shielding brain cells from stress, inflammation, and degeneration [Beurel et al., 2015].
In simple terms, by calming down GSK-3β, lithium acts like a molecular shield, protecting neurons from damage that drives both mood instability and neurodegenerative diseases.
Lithium and Suicide Prevention
Perhaps the most striking and consistent finding across decades of research is lithium’s effect on suicide risk.
- A BMJ 2013 meta-analysis (Cipriani et al.) found that lithium reduced suicide risk by about 60–70% in people with mood disorders compared to placebo or other mood stabilizers.
- Lithium reduced not only completed suicides but also suicide attempts and deaths from any cause.
- This effect appears independent of mood stabilization. In other words, lithium protects against suicide above and beyond its ability to control manic or depressive episodes.
How Does Lithium Lower Suicide Risk?
Several mechanisms have been proposed:
- Impulse control: Lithium appears to reduce impulsive aggression, making suicidal acts less likely in moments of crisis.
- Emotional regulation: By stabilizing amygdala activity, lithium may prevent overwhelming emotional surges.
- Neuroprotection: Long-term brain changes may reduce the chronic stress and emotional dysregulation that drive suicidal thoughts.
This unique property has made lithium the gold standard in suicide prevention among people with bipolar disorder and recurrent depression.
Lithium in Drinking Water and Public Health
One of the most fascinating lines of evidence comes not from clinics, but from the environment.
Natural Trace Lithium in Water
In several regions worldwide, trace amounts of lithium naturally occur in groundwater. Researchers have compared suicide rates across areas with high vs. low lithium content in drinking water.
- In Austria, higher natural lithium levels were associated with significantly lower suicide rates (Kapusta et al., Br J Psychiatry, 2011).
- A Danish nationwide study (Kessing et al., JAMA Psychiatry, 2017) found that people living in areas with more lithium in drinking water had reduced risk of dementia and possibly lower suicide rates.
These findings suggest that even microdoses of lithium, far below clinical levels, may have measurable effects on population mental health.
Low-Dose and Microdose Lithium
Standard therapeutic doses for bipolar disorder involve 600–1200 mg of lithium carbonate daily, aiming for blood levels of 0.6–1.2 mmol/L. At these levels, monitoring of kidney and thyroid function is crucial due to potential side effects.
But researchers are now asking: What about much lower doses—such as 1 to 10 mg per day?
Evidence for Low-Dose Benefits
The most intriguing aspect of lithium research today is that benefits may occur even at doses far below traditional psychiatric levels.
- Animal studies: In Alzheimer’s disease models, microdoses of lithium reduced amyloid-β plaque accumulation and protected neurons from oxidative stress and cell death (Nunes et al. 2015). These results suggest that even trace exposure can influence brain pathways linked to aging and neurodegeneration.
- Human trials: In a randomized controlled study, patients with amnestic mild cognitive impairment who took 300 µg/day of lithium carbonate showed slower cognitive decline and lower levels of phosphorylated tau protein compared to those on placebo (Forlenza et al. 2011). This provides some of the first direct clinical evidence that microdoses may modify disease progression.
- Population studies: Large-scale ecological research in Austria found that communities with naturally higher lithium levels in drinking water had significantly lower suicide rates compared to regions with less lithium exposure (Kapusta et al. 2011). Even at intakes under 1 mg per day, lithium appeared to influence mental health outcomes at the population level.
Taken together, these findings suggest that lithium’s protective effects may extend beyond psychiatry into public health and neurodegeneration. While much more research is needed, the idea that microdoses of a simple mineral could improve resilience against both mood disorders and dementia is one of the most promising frontiers in neuroscience.
Lithium and Neurodegenerative Diseases
Because lithium protects neurons, reduces abnormal protein buildup, and stimulates new cell growth, it is being actively studied in:
- Alzheimer’s disease
- Parkinson’s disease
- Amyotrophic lateral sclerosis (ALS)
While results are preliminary, low-dose lithium is viewed as a potential disease-modifying agent for conditions where the brain progressively degenerates.
Safety Considerations
At full therapeutic doses, lithium is a powerful drug but requires careful monitoring:
- Kidney function can be affected with long-term use.
- Thyroid suppression may occur.
- Blood levels must be checked regularly to avoid toxicity.
At microdoses, these risks are far lower, but research is ongoing to confirm long-term safety.
I use the product below.
Lithium Orotate 5mg of Elemental Lithium for Cognition and Brain Health
As an Amazon Associate, I earn from qualifying purchases
Conclusion
Lithium is more than just a mood stabilizer—it is a neuroprotective agent, a suicide prevention tool, and possibly a brain health enhancer even at microdoses.
- In the brain, lithium increases the volume of the hippocampus and amygdala, supports neurogenesis, and protects neurons from damage.
- In mental health, lithium remains unmatched in reducing suicide risk, a finding replicated across decades and populations.
- In public health, even trace amounts of lithium in drinking water may protect against both suicide and dementia.
While full-dose lithium therapy is not for everyone and requires medical supervision, the potential of low-dose lithium for population brain health is one of the most exciting frontiers in neuroscience today.
As research continues, lithium stands as a reminder that sometimes the simplest minerals can have the most profound effects on the human mind.
Don’t Get Sick!
💡 Support This Work
Creating well-researched articles, maintaining this website, and keeping the information free takes time and resources.
If you found this article helpful, please consider donating to support the mission of empowering people to live healthier, longer lives, without relying on medications.
🙏 Every contribution, big or small, truly makes a difference. Thank you for your support!
Follow me on Facebook, Gab, Twitter (formerly known as X), and Telegram.
Lowering all-cause mortality
- The Amazing Lithium for COVID-19 and Long COVID
- HDL Raising Drugs Do Not Improve Cardiovascular and All-Cause Mortality
- 7000 Steps Can Save Your Heart, Brain, And Prolong Life
- Stronger Handgrip, Longer Life: What Science Now Shows
- Reduced Flexibility, Shorter Life? What This 29-Year Study Reveals
- Physical Activity Prolongs Life
- Stunning Low Doses Of Lithium Really Improve Survival
- Your Calf Muscles Could Predict Your Lifespan
- Blue Spaces, Longer Lives: Unlock Nature’s Hidden Advantage
- Low Testosterone, Higher Mortality: What Two Major Studies Reveal About Hormone Health and How to Boost It Naturally
- Pfizer and Moderna shots increase all cause mortality: Denmark study
- Big Heart Benefits From Small Efforts: Discover VILPA
- Exercise Or Statins? Choose The Powerful Path To Longevity
- Unlock Longevity Now: 8 Healthy Habits That Defy Death
- How A Duchenne Smile Boosts Mood, Love, And Longevity
- The Sit and Rise Test Predicts How Long You’ll Live
References:
- Cipriani, Andrea, et al. “Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis.” BMJ, 2013; 346:f3647.
- Hallahan, Brian, et al. “Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data.” Bipolar Disorders, vol. 13, no. 1, 2011, pp. 1–12. https://pubmed.ncbi.nlm.nih.gov/21030008/
- Hajek, Tomas, et al. “Brain structural changes in bipolar disorder with a focus on lithium: a critical review.” Cellular and Molecular Neurobiology, vol. 29, no. 3, 2009, pp. 231–243.
- Kapusta, Nestor D., et al. “Lithium in drinking water and suicide mortality.” British Journal of Psychiatry, vol. 198, no. 5, 2011, pp. 346–350.
- Kessing, Lars Vedel, et al. “Lithium in drinking water and the incidence of dementia.” JAMA Psychiatry, vol. 74, no. 10, 2017, pp. 1005–1010.
- Nunes, Marcia A., et al. “Lithium treatment prevents stress-induced reduction of hippocampal neurogenesis and memory impairment in mice.” Journal of Alzheimer’s Disease, vol. 45, no. 3, 2015, pp. 795–805.
- Nunes, M. A., Viel, T. A., & Buck, H. S. “Microdose Lithium Treatment Stabilized Cognitive Impairment in Patients with Alzheimer’s Disease.” Journal of Alzheimer’s Disease, vol. 45, no. 3, 2015, pp. 975–983. doi:10.3233/JAD-142120.
- Forlenza, Orestes V., et al. “Disease-Modifying Properties of Long-Term Lithium Treatment for Amnestic Mild Cognitive Impairment: Randomized Controlled Trial.” The British Journal of Psychiatry, vol. 198, no. 5, 2011, pp. 351–356. doi:10.1192/bjp.bp.110.080044.
- Klein, Peter S., and Donald A. Melton. “A molecular mechanism for the effect of lithium on development.” Proceedings of the National Academy of Sciences, vol. 93, no. 16, 1996, pp. 8455–8459.
- Jope, Richard S. “Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes.” Trends in Pharmacological Sciences, vol. 24, no. 9, 2003, pp. 441–443.
- Beurel, Eléonore, et al. “Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.” Pharmacology & Therapeutics, vol. 148, 2015, pp. 114–131.
© 2018 – 2025 Asclepiades Medicine, LLC. All Rights Reserved
DrJesseSantiano.com does not provide medical advice, diagnosis, or treatment
As an Amazon Associate, I earn from qualifying purchases
Discover more from Don't Get Sick!
Subscribe to get the latest posts sent to your email.